MedTrace Logo

Best End-Expiratory and Driving-pressure for Individualized Flow Controlled Ventilation in Patients With COPD

NCT05812365 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2024-07-25

No results posted yet for this study

Summary

Patients with chronic obstructive pulmonary disease (COPD) have a significantly increased risk of postoperative pulmonary complications (PPC). Protective ventilation of the lungs could reduce the rate of PPC in patients with COPD. It has been suggested that flow controlled ventilation (FCV) may be less invasive and more protective to the lungs than conventional ventilation in patients with COPD.

The primary aim of this study is to determine a optimal individual ventilation setting for FCV in ten participants with COPD.

Conditions

  • COPD
  • Ventilator Lung
  • Anesthesia

Sponsors & Collaborators

  • Ventinova Medical, Eindhoven, Netherlands

    collaborator UNKNOWN

  • Timple SA, Rua Simao Álvares 356 Conj. 41,42 e 51 - Pinheiros, Sao Paulo (Brasilien)

    collaborator UNKNOWN

  • Universitätsklinikum Hamburg-Eppendorf

    lead OTHER

Principal Investigators

  • André Dankert, MD · Universitätsklinikum Hamburg-Eppendorf

  • Martin Petzoldt, MD · Universitätsklinikum Hamburg-Eppendorf

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-01
Primary Completion
2024-07-24
Completion
2024-07-24

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05812365 on ClinicalTrials.gov